The window of opportunity for treating vulvovaginal atrophy in menopause: Insights from oestrogen receptor distribution and age-related changes

Key Points

• Vulvovaginal atrophy treatment appears effective, especially when targeting oestrogen receptor activity.
• Key metric highlights that hormonal therapy can significantly improve symptoms in middle-aged women.
• Observational analysis reveals insights from oestrogen receptor distribution and age-related changes.
• This may enable timely interventions in menopause, suggesting that early treatment is crucial.